Prasugrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis of Randomized Trials.
Avik RayAhmad NajmiGaurav KhandelwalRatinder JhajBalakrishnan SadasivamPublished in: Cardiovascular drugs and therapy (2020)
In patients with ACS undergoing PCI, both prasugrel and ticagrelor were associated with similar cardiovascular outcomes and adverse bleeding events.